Skip to main content

Table 2 Antibiotic susceptibility data of Cellulosimicrobium species (or Oerskovia) in reported cases

From: Infections due to Cellulosimicrobium species: case report and literature review

 

All species

C. cellulans

C. funkei

No. of isolates

MIC range (mg/L)

% Susceptibility

No. of isolates

% Susceptibility

No. of isolates

% Susceptibility

AMC

4

1/0.5–16/8

50%

4

50%

AMK

11

4–16

73%

7

57%

3

100%

CFZ

9

1–8

67%

8

75%

CIP

15

1 - > 8

13%

12

17%

0

0%

CLI

13

2–8

8%

12

0%

CTX

7

8–64

29%

5

20%

2

50%

ERY

19

1–16

26%

13

15%

4

50%

GEN

14

2–16

43%

9

11%

4

100%

IMP

8

<  0.25 - > 16

75%

6

83%

2

50%

LNZ

4

0.5–1

100%

4

100%

PEN

24

0.012–4

25%

17

18%

4

25%

RIF

12

<  0.5–4

75%

9

78%

3

67%

SXT

20

<  0.06/1.19–8/152

85%

15

93%

4

50%

TET

16

1–8

50%

13

54%

2

50%

VAN

30

≤ 0.25 - < 4

100%

23

100%

5

100%

  1. AMC Amoxicillin-clavulanate, AMK Amikacin, CFZ Cefazolin, CIP Ciprofloxacin, CLI Clindamycin, CTX Cefotaxime, ERY Erythromycin, GEN Gentamycin, IMP Imipenem, LNZ Linezolid,
  2. MIC Minimum inhibitory concentration, PEN Penicillin, RIF Rifampin, SXT Trimetroprim-sulfamethoxazole, TET Tetracycline, VAN Vancomycin